InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by ABALLI JOHN, Chief Executive Officer. Officer active across 1 companies, notably EXAGEN INC.. Cumulatively, 4 filings have been published. Total volume traded: €712k. The latest transaction was disclosed on 24 February 2026 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
US$34,98611,430 shares@ US$3.06090.040% mcap9.8% of flow
Common Stock
SEC:0001843113-26-000002·
€34,98611,430 shares@ €3.06090.040% mcap4.9% of flow
Common Stock
SEC:0001843113-26-000002:0·
US$321,03531,787 shares@ US$10.09960.37% mcap90.2% of flow
Common Stock
SEC:0001843113-25-000003·
€321,03531,787 shares@ €10.09960.37% mcap45.1% of flow
Common Stock
SEC:0001843113-25-000003:0·
4 of 4 declarations
About ABALLI JOHN
John Aballi is the President and Chief Executive Officer of EXAGEN INC. He leads the company in developing diagnostic solutions, aiming to enhance healthcare. His expertise in business and technology is an asset for EXAGEN.
